Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Short Communication

Outcomes of Liver Transplantation from Deceased Donors with Coronavirus- Disease 2019 and Late Complications of Infection

Author(s): Mohsen Aliakbarian, Rozita Khodashahi *, Kambiz Akhavan Rezayat , Seyed Mousal-Reza Hosseini, Ebrahim Khaleghi and Soheila Milani

Volume 18, Issue 1, 2022

Published on: 27 January, 2022

Page: [4 - 7] Pages: 4

DOI: 10.2174/1573398X17666211209153335

Price: $65

Abstract

Background: The transplant patients should be considered a main high-risk population during the COVID-19 outbreak due to the use of immunosuppressive regimens and comorbidities.

Objective: This study aimed to evaluate the possibility of COVID-19 transmission by liver transplantation from a donor with a late complication of COVID-19 to the recipients.

Methods: This descriptive study was conducted on all the recipients of liver transplantation who had an acute liver failure or were the models for the End-Stage Liver Disease (MELD) higher than 20.

Results: In general, 36 liver transplantation was performed during the study period. Out of these patients, only 14 cases (deceased donors) had hemorrhagic cerebrovascular accidents, and other donors died of trauma (n=7) and anoxia (n=15). All patients showed negative results for polymerase chain reaction (PCR) (two negative 24 h PCR), whereas their high-resolution computed tomography (HRCT) test revealed that they had previously lung involvement with COVID-19 as the late complication of the disease.

Conclusion: This study supports the safety of continuing donation and transplant process during the outbreak even the transplant donor be infected previously with the COVID-19, which is reinforced by other similar pieces of evidence.

Keywords: Brain death, covid-19, donors, liver transplantation, complications, infection.

« Previous Next »
[1]
Passamonti SM, Cannavò A, Trunzo V, Caporale V, Buonocore R, DeFeo TM. Solid organ transplantation in the coronavirus disease 2019 era: “The Great Bet” in the North Italy Transplant Program Area. Transplant Proc 2020; 52(9): 2631-6.
[http://dx.doi.org/10.1016/j.transproceed.2020.07.001] [PMID: 32723520]
[2]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[3]
Michaels MG, La Hoz RM, Danziger-Isakov L, et al. Coronavirus disease 2019: Implications of emerging infections for transplantation. Am J Transplant 2020; 20(7): 1768-72.
[http://dx.doi.org/10.1111/ajt.15832] [PMID: 32090448]
[4]
Kates OS, Fisher CE, Rakita RM, Reyes JD, Limaye AP. Use of SARS-CoV-2-infected deceased organ donors: Should we always “just say no?”. Am J Transplant 2020; 20(7): 1787-94.
[http://dx.doi.org/10.1111/ajt.16000] [PMID: 32400087]
[5]
Lembach H, Hann A, McKay SC, et al. Resuming liver transplantation amid the COVID-19 pandemic. Lancet Gastroenterol Hepatol 2020; 5(8): 725-6.
[http://dx.doi.org/10.1016/S2468-1253(20)30187-4] [PMID: 32534603]
[6]
Saigal S, Gupta S, Sudhindran S, et al. Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI). Hepatol Int 2020; 14(4): 429-31.
[http://dx.doi.org/10.1007/s12072-020-10041-1] [PMID: 32270388]
[7]
Hui DS, Azhar EI, Kim Y-J, Memish ZA, Oh MD, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis 2018; 18(8): e217-27.
[http://dx.doi.org/10.1016/S1473-3099(18)30127-0] [PMID: 29680581]
[8]
Akalin E, Azzi Y, Bartash R, et al. Covid-19 and kidney transplantation. N Engl J Med 2020; 382(25): 2475-7.
[http://dx.doi.org/10.1056/NEJMc2011117] [PMID: 32329975]
[9]
Alberici F, Delbarba E, Manenti C, et al. Brescia Renal COVID Task Force. Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep 2020; 5(5): 580-5.
[http://dx.doi.org/10.1016/j.ekir.2020.04.001] [PMID: 32292866]
[10]
Donato MF, Invernizzi F, Lampertico P, Rossi G. Health status of patients who underwent liver transplantation during the coronavirus outbreak at a large center in Milan, Italy. Clin Gastroenterol Hepatol 2020; 18(9): 2131-3.
[http://dx.doi.org/10.1016/j.cgh.2020.04.041] [PMID: 32334081]
[11]
Xiao Y, Pan H, She Q, Wang F, Chen M. Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis. Lancet Gastroenterol Hepatol 2020; 5(6): 528-9.
[http://dx.doi.org/10.1016/S2468-1253(20)30080-7] [PMID: 32197093]
[12]
Maggi U, De Carlis L, Yiu D, et al. The impact of the COVID-19 outbreak on liver transplantation programs in Northern Italy. Am J Transplant 2020; 20(7): 1840-8.
[http://dx.doi.org/10.1111/ajt.15948] [PMID: 32330351]
[13]
Coronavirus and chronic liver disease and post-transplant reporting database. 2020.
[14]
Liu H, He X, Wang Y, et al. Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation. Hepatol Int 2020; 14(4): 432-6.
[http://dx.doi.org/10.1007/s12072-020-10043-z] [PMID: 32277387]
[15]
Ahn J, Bhuket T, Mosadeghi S, Frenette C, Liu B, Wong RJ. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients. Hepatol Int 2016; 10(5): 838-46.
[http://dx.doi.org/10.1007/s12072-016-9735-4] [PMID: 27221700]
[16]
Niriella MA, Siriwardana RC, Perera MTPR, Narasimhan G, Chan SC, Dassanayake AS. Challenges for liver transplantation during recovery from the covid-19 pandemic: Insights and recommendations. Transplant Proc 2020; 52(9): 2601-6.
[http://dx.doi.org/10.1016/j.transproceed.2020.05.032] [PMID: 32586665]

Rights & Permissions Print Cite
Article Metrics
27
1
© 2024 Bentham Science Publishers | Privacy Policy